Transdermal Use of Lisuride in Early Parkinson's Disease: A double blind, randomized, Placebo and Pramipexole controlled study to evaluate the efficacy and safety of Lisuride TTS.
Phase of Trial: Phase III
Latest Information Update: 30 Jan 2014
At a glance
- Drugs Lisuride (Primary) ; Pramipexole
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- Acronyms TULEP-1
- Sponsors axxonis Pharma
- 22 Jul 2011 This trial is recruiting in Germany and Poland and has completed in Italy.
- 22 Jul 2011 New trial record